Wave Life Sciences, Inc. (WVE) stock
WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.84−0.03 (-1.05%)
Close on Nov 17, 2026Market cap $560.13MP/E –Yield –
Wave Life Sciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Wave Life Sciences's profit margin for the twelve months ending Sep 30, 2026 was -296.9%. For fiscal 2025 it was -478.3%, against -89.6% the year before. The highest annual figure on record is -50.8% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -478.3% | −388.8 |
| FY2024 | Dec 31, 2024 | -89.6% | −38.8 |
| FY2023 | Dec 31, 2023 | -50.8% | +4384.0 |
| FY2022 | Dec 31, 2022 | -4434.7% | −4136.3 |
| FY2021 | Dec 31, 2021 | -298.4% | +448.3 |
| FY2020 | Dec 31, 2020 | -746.7% | +464.8 |
| FY2019 | Dec 31, 2019 | -1211.5% | −194.1 |
| FY2018 | Dec 31, 2018 | -1017.4% | +1602.1 |
| FY2017 | Dec 31, 2017 | -2619.6% | +2477.5 |
| FY2016 | Dec 31, 2016 | -5097.1% | +7534.5 |
| FY2015 | Dec 31, 2015 | -12631.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -470.5% | +237.3 |
| Q2 FY2026 | Jun 30, 2026 | -3052.6% | −2472.4 |
| Q1 FY2026 | Mar 31, 2026 | -68.2% | +442.7 |
| Q4 FY2025 | Dec 31, 2025 | -308.4% | −141.2 |
| Q3 FY2025 | Sep 30, 2025 | -707.8% | −456.1 |
| Q2 FY2025 | Jun 30, 2025 | -580.2% | −524.2 |
| Q1 FY2025 | Mar 31, 2025 | -510.9% | −525.7 |
| Q2 FY2024 | Jun 30, 2024 | -167.2% | −71.7 |
| Q1 FY2024 | Mar 31, 2024 | -251.7% | −39.7 |
| Q4 FY2023 | Dec 31, 2023 | -55.9% | +3471.8 |
| Q3 FY2023 | Sep 30, 2023 | 14.7% | +13700.3 |
| Q2 FY2023 | Jun 30, 2023 | -95.5% | +10916.8 |
| Q1 FY2023 | Mar 31, 2023 | -212.0% | +1948.8 |
| Q4 FY2022 | Dec 31, 2022 | -3527.8% | −1556.9 |
| Q3 FY2022 | Sep 30, 2022 | -13685.6% | −13668.5 |
| Q2 FY2022 | Jun 30, 2022 | -11012.3% | −9615.8 |
| Q1 FY2022 | Mar 31, 2022 | -2160.8% | −1855.8 |
| Q4 FY2021 | Dec 31, 2021 | -1970.8% | −1011.4 |
| Q3 FY2021 | Sep 30, 2021 | -17.1% | +1321.8 |
| Q2 FY2021 | Jun 30, 2021 | -1396.5% | −255.1 |
| Q4 FY2020 | Dec 31, 2020 | -305.0% | +2060.4 |
| Q3 FY2020 | Sep 30, 2020 | -959.4% | +772.4 |
| Q2 FY2020 | Jun 30, 2020 | -1338.9% | −789.0 |
| Q1 FY2020 | Mar 31, 2020 | -1141.4% | +319.3 |
| Q4 FY2019 | Dec 31, 2019 | -2365.4% | −1318.8 |
| Q3 FY2019 | Sep 30, 2019 | -1731.9% | −894.3 |
| Q2 FY2019 | Jun 30, 2019 | -549.8% | +185.8 |
| Q1 FY2019 | Mar 31, 2019 | -1460.7% | +1017.6 |
| Q4 FY2018 | Dec 31, 2018 | -1046.6% | +1757.9 |
| Q3 FY2018 | Sep 30, 2018 | -837.5% | +1101.2 |
| Q2 FY2018 | Jun 30, 2018 | -735.7% | +1506.5 |
| Q1 FY2018 | Mar 31, 2018 | -2478.3% | +3029.8 |
| Q4 FY2017 | Dec 31, 2017 | -2804.5% | −74.6 |
| Q3 FY2017 | Sep 30, 2017 | -1938.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -2242.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -5508.1% | – |
| Q4 FY2016 | Dec 31, 2016 | -2729.9% | – |
See a number that looks wrong?